Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Maureen Okam Achebe, MD, MPH
Healthcare Provider Clinical Director
Non-Malignant Hematology Clinic
Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, Massachusetts, United States
Dr. Maureen M. Okam studied medicine at University of Port Harcourt Medical School (1995). Her interests are hematologic disorders, anemia, sickle cell disease and thalassemia, thrombosis and anticoagulant therapy, thrombocytopenia, myelodysplasia and myeloproliferative disorders.
Her current research focuses on the pre-clinical and clinical development of new agents for the treatment of hemoglobinopathies – sickle cell disease and thalassemia. Her on-going clinical evaluation of histone deacetylase inhibitors in the induction of fetal hemoglobin, is funded by the National Institutes of Health through a Harvard Blood Scholars research grant.
Appointments:
Clinical Director, Non-Malignant Hematology Clinic
Assistant Director, Brigham and Women’s Hospital Outpatient Infusion Center
Director, Brigham and Women’s Hospital Sickle Cell Program
Assistant Professor in Medicine, Harvard Medical School
+myBinderRelated Content
-
Cheryl Mensah, MDCheryl Mensah is an Assistant Professor ...
-
Severe Blood Shortage Due To Coronavirus OutbreakThe American Red Cross now faces a sever...
-
Physician Prescribing Practices in Sickle Cell DiseaseSickle cell disease (SCD) affects approx...
-
International Association of Sickle Cell Nurses and Professional AssociatesThe International Association of Sickle ...
-
Hope for SCDHope for SCD strives to bridge the gap b...
-
Petition: Implement NIH Guidelines in Hospital Emergency Rooms when Managing a Sickle Cell CrisisHELP US REACH 1,500 E-SIGNATURES BY DECE...
-
Pharmacogenetics for Safe Codeine Use in Sickle Cell DiseaseAfter postoperative deaths in children w...
